Yuichiro� Doki

Osaka Prefectural Medical Center (JP)

Research Areas

Discover Papers by Yuichiro� Doki

Access 250+ million papers and cite this researcher's work with AI assistance

Try AnswerThis Free →

H-index

100

Publications

2297

Citations

51754

i10-index

951

Publications & Citations Over Time

Top Cited Publications

Want to find and read papers by this researcher? AnswerThis gives you instant access.

Title	Year	Citations
Nivolumab versus chemotherapy in patients with adv...	2019	1218
Two FOXP3+CD4+ T cell subpopulations distinctly co...	2016	869
Reprogramming of Mouse and Human Cells to Pluripot...	2011	763
CD13 is a therapeutic target in human liver cancer...	2010	605
Esophageal cancer practice guidelines 2017 edited ...	2018	570
Esophageal cancer practice guidelines 2017 edited ...	2018	519
Exosomal microRNA in serum is a novel biomarker of...	2015	492
Guidelines for Diagnosis and Treatment of Carcinom...	2014	445
Thoracic and cardiovascular surgery in Japan durin...	2016	401
Nivolumab treatment for oesophageal squamous-cell ...	2017	378

Publications

1.
Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial
Year: 2019Citations: 1218DOI: 10.1016/s1470-2045(19)30626-6
2.
Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers
Year: 2016Citations: 869DOI: 10.1038/nm.4086
3.
Reprogramming of Mouse and Human Cells to Pluripotency Using Mature MicroRNAs
Year: 2011Citations: 763DOI: 10.1016/j.stem.2011.05.001
4.
CD13 is a therapeutic target in human liver cancer stem cells
Year: 2010Citations: 605DOI: 10.1172/jci42550
5.
Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2
Year: 2018Citations: 570DOI: 10.1007/s10388-018-0642-8
6.
Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1
Year: 2018Citations: 519DOI: 10.1007/s10388-018-0641-9
7.
Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer
Year: 2015Citations: 492DOI: 10.1038/bjc.2015.201
8.
Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society
Year: 2014Citations: 445DOI: 10.1007/s10388-014-0465-1
9.
Thoracic and cardiovascular surgery in Japan during 2014
Year: 2016Citations: 401DOI: 10.1007/s11748-016-0695-3
10.
Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial
Year: 2017Citations: 378DOI: 10.1016/s1470-2045(17)30181-x

About Yuichiro� Doki

Yuichiro� Doki is a researcher with 2297 publications and 51754 citations. They are affiliated with Osaka Prefectural Medical Center. Their research focuses on . With an h-index of 100, they are among the top researchers in their field.

Citation Distribution

Distribution of citations across publications

Research Smarter

AnswerThis uses AI to help you search, understand, and cite research from Yuichiro� Doki and 250M+ other papers.

AI-powered research assistance
Automatic citations and references
Advanced academic writing tools

Research Area Breakdown

Publication Types

Publication type data not available

Impact Metrics Over Time

Citations per publication by year